JP2009539912A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539912A5
JP2009539912A5 JP2009514714A JP2009514714A JP2009539912A5 JP 2009539912 A5 JP2009539912 A5 JP 2009539912A5 JP 2009514714 A JP2009514714 A JP 2009514714A JP 2009514714 A JP2009514714 A JP 2009514714A JP 2009539912 A5 JP2009539912 A5 JP 2009539912A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
molecule
preferably selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539912A (ja
JP5475441B2 (ja
Filing date
Publication date
Priority claimed from EP06090108A external-priority patent/EP1867647A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/005430 external-priority patent/WO2007144202A1/en
Publication of JP2009539912A publication Critical patent/JP2009539912A/ja
Publication of JP2009539912A5 publication Critical patent/JP2009539912A5/ja
Application granted granted Critical
Publication of JP5475441B2 publication Critical patent/JP5475441B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514714A 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類 Expired - Fee Related JP5475441B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06090108.9 2006-06-13
EP06090108A EP1867647A1 (en) 2006-06-13 2006-06-13 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
EP07090024 2007-02-22
EP07090024.6 2007-02-22
PCT/EP2007/005430 WO2007144202A1 (en) 2006-06-13 2007-06-12 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them

Publications (3)

Publication Number Publication Date
JP2009539912A JP2009539912A (ja) 2009-11-19
JP2009539912A5 true JP2009539912A5 (https=) 2013-05-16
JP5475441B2 JP5475441B2 (ja) 2014-04-16

Family

ID=38441698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514714A Expired - Fee Related JP5475441B2 (ja) 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類

Country Status (10)

Country Link
US (1) US7825114B2 (https=)
EP (1) EP2032572B1 (https=)
JP (1) JP5475441B2 (https=)
AR (1) AR061345A1 (https=)
CA (1) CA2654987C (https=)
CL (1) CL2007001710A1 (https=)
ES (1) ES2467017T3 (https=)
TW (1) TW200815437A (https=)
UY (1) UY30410A1 (https=)
WO (1) WO2007144202A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
NZ580660A (en) 2007-04-30 2012-02-24 Abbott Lab Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
EP2307456B1 (en) 2008-06-27 2014-10-15 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010059788A1 (en) 2008-11-20 2010-05-27 Genentech, Inc. Pyrazolopyridine pi3k inhibitor compounds and methods of use
US8846673B2 (en) 2009-08-11 2014-09-30 Bristol-Myers Squibb Company Azaindazoles as kinase inhibitors and use thereof
CN103214479A (zh) * 2012-01-18 2013-07-24 武汉东宇生物医药科技有限公司 吡唑类萘脲类酪氨酸激酶抑制剂及其应用
CN103923078A (zh) * 2013-01-15 2014-07-16 华东理工大学 3,4-二取代(1H-吡唑[3,4-b]吡啶)类化合物及其用途
CN103524421B (zh) * 2013-09-29 2015-04-01 镇江蓝德特药业科技有限公司 新型萘脲类衍生物及其医疗应用
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
AU2018346597B2 (en) 2017-10-06 2023-07-13 Forma Therapeutics, Inc. Inhibiting Ubiquitin Specific Peptidase 30
JP7050165B2 (ja) 2018-02-26 2022-04-07 ギリアード サイエンシーズ, インコーポレイテッド Hbv複製阻害剤としての置換ピロリジン化合物
JP7449242B2 (ja) 2018-05-17 2024-03-13 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物
JP7530889B2 (ja) 2018-10-05 2024-08-08 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的プロテアーゼ30(usp30)阻害剤として作用する縮合ピロリン
TW202330519A (zh) * 2021-09-29 2023-08-01 香港商德琪研發有限公司 作為tam抑制劑的吡唑并吡啶化合物
EP4452978A4 (en) * 2021-12-22 2025-12-17 Anaxis Pharma Pty Ltd BIFUNCTIONAL ARYLSULFONAMIDE COMPOUNDS
MX2024007885A (es) * 2021-12-22 2024-09-23 Anaxis Pharma Pty Ltd Compuestos de arilsulfonamida.
WO2023155886A1 (en) * 2022-02-17 2023-08-24 Shanghai Antengene Corporation Limited Pyrazolopyridine compounds as tam inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002938A (es) * 1999-09-17 2004-12-06 Abbott Gmbh & Co Kg Inhibidores de cinasa como agentes agentes terapeuticos.
DK1638941T3 (da) * 2003-05-22 2010-10-11 Abbott Lab Indazol-, benzisoxazol- og benzisothiazolkinaseinhibitorer
ATE554087T1 (de) * 2004-10-29 2012-05-15 Abbott Lab Neue kinaseinhibitoren

Similar Documents

Publication Publication Date Title
JP2009539912A5 (https=)
JP2009539914A5 (https=)
JP2009062537A5 (https=)
JP2012520247A5 (https=)
RU2011101140A (ru) Пирроло[2,3-b]пиридиновые производные в качестве ингибиторов протеинкиназ
JP2006096962A5 (https=)
JP2010520851A5 (https=)
JP2006508036A5 (https=)
JP2010523596A5 (https=)
JP2011121940A5 (ja) 発光素子
JP2013102146A5 (ja) 化合物
JP2009135422A5 (https=)
JP2010536766A5 (https=)
JP2015523439A5 (ja) 量子ドット結合用リガンド及び組成物
MX2007012090A (es) Derivados sustituidos de pirazoliloxifenilo como herbicidas.
JP2012006912A5 (ja) トリアゾール誘導体
JP2013509487A5 (https=)
JP2012092103A5 (https=)
JP2007508362A5 (https=)
CN110268003A (zh) 固化性化合物
EP1826196A3 (en) Vinyl ether compounds
JP2007246474A5 (https=)
JP2020504434A5 (https=)
JP2004535412A5 (https=)
JP2015510508A5 (https=)